Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 09, 2026
Dordaviprone Maintenance After Allogeneic HCT for High-Risk Acute Myeloid Leukemia and Myelodysplastic Neoplasm.
Journal: American journal of hematology
Published: February 19, 2026
Prognostic impact of impairments on geriatric assessment in older adults with acute myeloid leukemia.
Journal: Journal of geriatric oncology
Published: February 18, 2026
Platelet Factor 4 Antibody Persistence and Long-term Pathogenicity in Vaccine-induced Immune Thrombotic Thrombocytopenia.
Journal: medRxiv : the preprint server for health sciences
Published: December 08, 2025
Platelet factor 4 antibody persistence and long-term pathogenicity in vaccine-induced immune thrombotic thrombocytopenia.
Journal: Journal of thrombosis and haemostasis : JTH
Published: December 02, 2025
Hematopoietic Cell Transplantation, Version 3.2025, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: October 09, 2025
A phase I, single-arm, open-label, dose-escalation, multicenter study of SAR445419, an off-the-shelf, ex vivo expanded allogeneic natural killer cell product, in participants with relapsed or refractory acute myeloid leukemia.
Journal: Cancer immunology, immunotherapy : CII
Published: August 22, 2025
A Phase II Trial of Geriatric Assessment-Guided Selection of Treatment Intensity in Older Adults With AML.
Journal: American journal of hematology
Published: February 10, 2025
Corrigendum to 'Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial': [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714].
Journal: Journal of thrombosis and haemostasis : JTH
Published: December 21, 2024
Metabolic syndrome and symptom burden in allogeneic hematopoietic stem cell transplantation survivors.
Journal: Future oncology (London, England)
Published: November 24, 2024
A Multicenter Phase II Trial of Ruxolitinib for Treatment of Corticosteroid Refractory Sclerotic Chronic Graft-Versus-Host Disease.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 16, 2024
NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: June 11, 2024
Last Updated: 09/26/2026